Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 36 studies | 30% ± 13% | |
| smooth muscle cell | 20 studies | 33% ± 12% | |
| astrocyte | 17 studies | 38% ± 18% | |
| oligodendrocyte precursor cell | 12 studies | 39% ± 17% | |
| pericyte | 11 studies | 29% ± 14% | |
| connective tissue cell | 9 studies | 30% ± 12% | |
| myofibroblast cell | 9 studies | 33% ± 15% | |
| GABAergic neuron | 7 studies | 39% ± 16% | |
| interneuron | 6 studies | 38% ± 17% | |
| endothelial cell | 5 studies | 34% ± 16% | |
| glutamatergic neuron | 5 studies | 51% ± 19% | |
| mesothelial cell | 4 studies | 36% ± 18% | |
| epithelial cell | 3 studies | 29% ± 15% | |
| glial cell | 3 studies | 34% ± 9% | |
| granule cell | 3 studies | 24% ± 6% | |
| neuron | 3 studies | 34% ± 1% | |
| progenitor cell | 3 studies | 37% ± 8% | |
| Mueller cell | 3 studies | 17% ± 1% | |
| basal cell | 3 studies | 22% ± 6% | |
| amacrine cell | 3 studies | 27% ± 15% | |
| muscle cell | 3 studies | 31% ± 10% | |
| ependymal cell | 3 studies | 52% ± 20% | |
| adventitial cell | 3 studies | 25% ± 5% | |
| club cell | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 98% | 9710.44 | 450 / 459 | 96% | 114.69 | 1077 / 1118 |
| lung | 100% | 12431.82 | 577 / 578 | 94% | 72.33 | 1084 / 1155 |
| ovary | 100% | 21678.52 | 180 / 180 | 86% | 53.61 | 369 / 430 |
| prostate | 98% | 8395.73 | 240 / 245 | 87% | 44.30 | 435 / 502 |
| bladder | 100% | 11132.29 | 21 / 21 | 82% | 49.00 | 413 / 504 |
| uterus | 100% | 16464.61 | 170 / 170 | 82% | 48.60 | 376 / 459 |
| thymus | 99% | 10485.69 | 647 / 653 | 83% | 37.84 | 501 / 605 |
| esophagus | 91% | 8755.80 | 1318 / 1445 | 86% | 70.71 | 157 / 183 |
| skin | 100% | 14087.41 | 1805 / 1809 | 74% | 34.44 | 347 / 472 |
| brain | 67% | 2897.69 | 1759 / 2642 | 99% | 100.85 | 700 / 705 |
| intestine | 91% | 7580.17 | 876 / 966 | 73% | 52.22 | 386 / 527 |
| adrenal gland | 100% | 12442.57 | 258 / 258 | 61% | 22.32 | 140 / 230 |
| stomach | 48% | 2837.53 | 171 / 359 | 81% | 60.13 | 231 / 286 |
| kidney | 42% | 2113.37 | 37 / 89 | 77% | 38.29 | 691 / 901 |
| blood vessel | 100% | 43185.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 98% | 9915.76 | 1182 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 4% | 139.55 | 12 / 328 | 93% | 112.46 | 165 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 39.59 | 37 / 45 |
| heart | 69% | 4945.21 | 596 / 861 | 0% | 0 | 0 / 0 |
| spleen | 64% | 3051.43 | 155 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 44% | 11.73 | 35 / 80 |
| muscle | 23% | 911.04 | 186 / 803 | 0% | 0 | 0 / 0 |
| liver | 3% | 85.15 | 6 / 226 | 18% | 6.52 | 73 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 3.98 | 5 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_1901202 | Biological process | negative regulation of extracellular matrix assembly |
| GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
| GO_0022414 | Biological process | reproductive process |
| GO_0001568 | Biological process | blood vessel development |
| GO_0009986 | Cellular component | cell surface |
| GO_0010008 | Cellular component | endosome membrane |
| GO_0031527 | Cellular component | filopodium membrane |
| GO_0031258 | Cellular component | lamellipodium membrane |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0005518 | Molecular function | collagen binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ANTXR1 |
| Protein name | Anthrax toxin receptor 1 (Tumor endothelial marker 8) ANTXR cell adhesion molecule 1 ANTXR1 protein |
| Synonyms | TEM8 ATR |
| Description | FUNCTION: Plays a role in cell attachment and migration. Interacts with extracellular matrix proteins and with the actin cytoskeleton. Mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. Plays a role in the angiogenic response of cultured umbilical vein endothelial cells. .; FUNCTION: (Microbial infection) Acts as a receptor for protective antigen (PA) of B.anthracis. . |
| Accessions | A0A7P0T9B0 ENST00000409829.7 [Q9H6X2-4] ENST00000679548.1 ENST00000463335.2 [Q9H6X2-3] ENST00000303714.9 [Q9H6X2-1] H0YC24 ENST00000409349.7 [Q9H6X2-2] Q9H6X2 ENST00000681816.1 A0A7P0Z463 Q96EC6 ENST00000482235.2 |